Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.
Sehhoon ParkChan-Young OckHyojin KimSergio PereiraSeonwook ParkMinuk MaSangjoon ChoiSeokhwi KimSeunghwan ShinBrian Jaehong AumKyunghyun PaengDonggeun YooHongui ChaSunyoung ParkKoung Jin SuhHyun Ae JungSe Hyun KimYu Jung KimJong-Mu SunJin-Haeng ChungJin Seok AhnMyung-Ju AhnJong Seok LeeKeunchil ParkSang Yong SongYung-Jue BangYoon-La ChoiTony S K MokSe-Hoon LeePublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
The AI-powered spatial analysis of TIL correlated with tumor response and progression-free survival of ICI in advanced NSCLC. This is potentially a supplementary biomarker to TPS as determined by a pathologist.